Steroids in Diabetic Macular Edema
AARON M. YEUNG FRCOphth, PhD • MARK GILLIES FRANZCO, PhD
In sustained-release formats, these drugs have shown impressive evidence.
Treatment of DME Beyond Anti-VEGF
DANIEL D. ESMAILI, MD • DAVID S. BOYER, MD
The results with anti-VEGF drugs are impressive, but new target molecules could revolutionize DME care.
Intravitreal Aflibercept for Diabetic Macular Edema
JOHN F. PAYNE, MD • W. LLOYD CLARK, MD
We review the data on which approval of the newest anti-VEGF drug for DME was based.
Vitrectomy for Diabetic Macular Edema
BOZHO TODORICH, MD, PhD • HARRY W. FLYNN, JR., MD • TAMER H. MAHMOUD, MD, PhD
What do we know, and when is vitrectomy indicated?
IRIS Springs Into Action
RISHI P. SINGH, MD
The AAO’s registry, in combination with EHR, could be a valuable resource for retinal physicians.
Inventory Systems Keep Track of Injectables
Physicians can keep tabs, identify usage trends, assist with billing accuracy, and more.
Peter K. Kaiser, MD
Don’t Swing at Every Pitch
BY JERRY HELZNER, CONTRIBUTING EDITOR
RECENT NOTEWORTHY STUDIES TO STIMULATE DISCUSSION AND DEBATE
PAUL E. TORNAMBE, MD
What Do I Think About 25% Vitrectomy Surgery Cuts — Bucket!
SUZANNE L. CORCORAN, COE
Ring in the Old, the New — and the Reduced
Innovation in Retina
EDITED BY EMMETT T. CUNNINGHAM, JR, MD, PhD, MPH, AND PRAVIN U. DUGEL, MD
Anthony P. (Tony) Adamis, MD
BY KAREN APPOLD, CONTRIBUTING WRITER
All-in-one Pattern Scanning Laser/Slit Lamp Does It All With Ease